Achillion Pharmaceuticals

- NASDAQ:ACHN
Last Updated 2020-05-04
  • Achillion Pharmaceuticals is engaged in the discovery, development and commercialization of treatments for infectious diseases.
  • Locations

    • New Haven CT
  • Total Funding (USD)

    91.1 million
  • Industries

    Internet, Software, Cyber Security
  • Security

    Type: ORD
    CUSIP: 00448Q201
    ISIN: US00448Q2012
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.